M. Bertrand

发表

Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study

K. Baumstarck, P. Auquier, T. Lambert, 2018, BMJ Open.

Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost – the ‘Statut Orthopédique des Patients Hémophiles’ avec Inhibiteur study

T. Lambert, M. Bertrand, A. Borel‐Derlon, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

LETTERS TO THE EDITOR: Four cases of hypofibrinogenemia associated with four novel mutations

M. Bertrand, C. Vinciguerra, M. Hanss, 2005, Journal of thrombosis and haemostasis : JTH.

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients

T. Lambert, M. Bertrand, V. Gay, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases

E. Deconinck, M. Bertrand, J. Cahn, 2002, Transplantation.

Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors

C. Rothschild, M. Bertrand, J. Goudemand, 1997, Thrombosis and Haemostasis.

Comparison of Anti‐Human and Anti‐Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia A

M. Torchet, M. Bertrand, B. Boneu, 1993, Vox sanguinis.

Cost related to replacement therapy during hospitalization in haemophiliacs with or without inhibitors: experience of six French haemophilia centres

M. Bertrand, A. Berthier, P. Gautier, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.

K. Baumstarck, P. Moreau, T. Lambert, 2021, The Journal of pediatrics.

Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres

M. Bertrand, M. Briquel, A. Faradji, 2008, Pharmacy World & Science.

Hemarthrosis in acquired hemophilia. Two case-reports.

M. Bertrand, D. Wendling, 2003, Joint, bone, spine : revue du rhumatisme.

Comparison of Anti-Human and Anti-Porcine Factor Vlll Inhibitor

M. Torchet, M. Bertrand, B. Boneu, 2009 .

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies

A. Chuansumrit, G. Mariani, G. Auerswald, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patients

M. Bertrand, J. Goudemand, C. Trépo, 2001, European journal of gastroenterology & hepatology.

Incidence of Factor VIII Inhibitor Development in Severe Hemophilia A Patients Treated only with One Brand of Highly Purified Plasma-Derived Concentrate

C. Rothschild, M. Bertrand, C. Négrier, 1995, Thrombosis and Haemostasis.

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

R. Favier, M. Torchet, M. Bertrand, 2004, Haematologica.

Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort

M. Bertrand, V. Gay, H. Chambost, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance

M. Bertrand, B. Frotscher, G. Mourey, 2014, Thrombosis and Haemostasis.

Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists: Comment on the article "Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis" by Banse et al., Joint Bone Spine 2015;82:200-2.

M. Bertrand, D. Wendling, X. Guillot, 2015, Joint, bone, spine : revue du rhumatisme.